Samsung gets FDA clearance for irregular heart rhythm notifications

Samsung announced today that it received clearance from the Food and Drug Administration for a forthcoming irregular heart rhythm notification feature for its Galaxy Watches. This is meant to work alongside its FDA-cleared EKG feature and first arrive on its upcoming Galaxy Watch 6.

Functionally, it’s more similar to Fitbit’s passive AFib monitoring feature that was introduced last year than the EKG spot-checks Apple introduced with the Series 4 in 2018. Unlike the EKG measurements, these irregular heart rhythm notifications don’t require the user to do anything. Once enabled, the Galaxy Watch will monitor for irregular heart rate rhythms in the background and will only alert users once a certain number of consecutive measurements are...

Continue reading…